ESC Premium Access

Interactive debate: should there be greater emphasis on combination therapy, particularly fixed-dose combinations, in the treatment guidelines?

Presentation

About the speakers

Doctor Alejandro De La Sierra

Hospital University Mutua de Terrassa, Terrassa (Spain)
5 presentations
0 follower

Professor Bryan Williams

University College London, London (United Kingdom of Great Britain & Northern Ireland)
50 presentations
1 follower

Professor Michel Burnier

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)
12 presentations
0 follower

Professor Massimo Volpe

Polyclinic Umberto I, Rome (Italy)
11 presentations
0 follower

5 more presentations in this session

Welcome and introduction: renin-angiotensin system blockade as the basis for combination therapy.

Speaker: Professor M. Burnier (Lausanne, CH)

Thumbnail

Maximising benefits of fixed-dose combinations.

Speaker: Professor B. Williams (London, GB)

Thumbnail

Angiotensin receptor blocker-based single-pill platform: a practical approach.

Speaker: Professor M. Volpe (Rome, IT)

Thumbnail

Combination therapies and BP control: the spanish hypertension registry experience.

Speaker: Doctor A. De La Sierra (Terrassa, ES)

Thumbnail

Summary and meeting close - Achieving better blood pressure control with fixed-dose combination therapy.

Speaker: Doctor A. De La Sierra (Terrassa, ES)

Thumbnail

Access the full session

Achieving better blood pressure (BP) control with fixed-dose combination (FDC) therapy

Speakers: Doctor A. De La Sierra, Professor B. Williams, Professor M. Burnier, Professor M. Volpe, Professor M. Burnier...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk